{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-012850","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2026-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.653620+00:00","generated_at":"2026-05-15T05:24:54.191816+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"NRC Health declassifies board, formalizes name change; CFO restricted stock amended","bullets":["Name changed to NRC Health from National Research Corp; 'NRC' ticker unchanged; no shareholder vote required.","Board declassified: all directors will face annual elections; five directors resigned residual terms effective before June 23, 2026 meeting.","Resigning directors: Berwick, Green, Hays, Lockhart, Nunnelly; all seven incumbents nominated for reelection at 2026 annual meeting.","CFO Shane Harrison's restricted stock award (172,000 shares, Sept 2025) amended to permit voting and dividends on unvested shares.","Amended Bylaws set max board size at 12, update meeting/notice deadlines, and formalize Chair position."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-012850","json":"https://secwatch.observer/filing/0001437749-26-012850.json","markdown":"https://secwatch.observer/filing/0001437749-26-012850.md","text":"https://secwatch.observer/filing/0001437749-26-012850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/nrc20260409_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:24:54.191816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5ff911b33626badf7145ea656bafdabd8c53f61f","claim":"NRC HEALTH: Changed corporate name to NRC Health pursuant to amendment to certificate of incorporation (effective 2026-04-15).","evidence_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","confidence":0.9},{"claim_id":"6229f8eeef9f110496e09a5c1878dc9728e3c1ae","claim":"NRC HEALTH: Adopted amended and restated Bylaws declassifying the Board of Directors and making other changes (effective 2026-04-15).","evidence_excerpt":"Also on April 15, 2026, the Company’s Board of Directors (the “Board”) adopted and approved, effective April 15, 2026, amended and restated Bylaws of the Company (as amended and restated, the “A&R Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001104659-26-057731","ticker":"AEIS","company_name":"ADVANCED ENERGY INDUSTRIES INC","filed_at":"2026-05-08T23:59:59+00:00","headline":"AEIS stockholders approve doubling of authorized shares to 140M and expansion of equity plan to 4.9M shares","event_type":"other_material","sec_items":["5.02","5.07","5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057731","json":"https://secwatch.observer/filing/0001104659-26-057731.json","markdown":"https://secwatch.observer/filing/0001104659-26-057731.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/927003/000110465926057731/0001104659-26-057731-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927003/000110465926057731/tm2612734d2_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"the amendment increases the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares. The amendment became effective upon the filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 7, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/927003/000110465926057731/0001104659-26-057731-index.htm"}},{"accession":"0001193125-26-214945","ticker":"MAN","company_name":"ManpowerGroup Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"ManpowerGroup declares $0.72 dividend; shareholders approve equity plan amendment and director removal without cause","event_type":"other_material","sec_items":["5.02","5.03","5.07","8.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-214945","json":"https://secwatch.observer/filing/0001193125-26-214945.json","markdown":"https://secwatch.observer/filing/0001193125-26-214945.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/0001193125-26-214945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/man-20260508.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"the Board of Directors of the Company amended Section 3.3 of Article III of the Company’s Amended and Restated By-Laws (the “ By-Laws Amendment ”) to permit the removal of a director with or without cause by the affirmative vote of two-thirds of the outstanding shares of capital stock of the Company entitled to vote at a meeting of shareholders duly called for such purpose. The effective date of the By-Laws Amendment is May 8, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/0001193125-26-214945-index.htm"}},{"accession":"0001193125-26-208963","ticker":"RYZ","company_name":"Ryerson Holding Corp","filed_at":"2026-05-06T23:59:59+00:00","headline":"Ryerson stockholders approve 1.5M share increase in 2014 incentive plan; director Calhoun departs","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-208963","json":"https://secwatch.observer/filing/0001193125-26-208963.json","markdown":"https://secwatch.observer/filing/0001193125-26-208963.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1481582/000119312526208963/0001193125-26-208963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1481582/000119312526208963/d149850d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"On April 30, 2026, at the Annual Meeting, upon the recommendation of the Board, the stockholders of the Company approved a proposal to amend and restate the Company’s Amended and Restated Certificate of Incorporation (the “Amended and Restated Charter”) to provide for the exculpation of certain of the Company’s officers in specific circumstances, as permitted by Delaware law.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1481582/000119312526208963/0001193125-26-208963-index.htm"}},{"accession":"0000051143-26-000043","ticker":"IBM","company_name":"INTERNATIONAL BUSINESS MACHINES CORP","filed_at":"2026-05-01T23:59:59+00:00","headline":"IBM annual meeting: 2026 LTPP approved, all directors elected, stockholder proposals defeated","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000051143-26-000043","json":"https://secwatch.observer/filing/0000051143-26-000043.json","markdown":"https://secwatch.observer/filing/0000051143-26-000043.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/51143/000005114326000043/0000051143-26-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/51143/000005114326000043/ibm-20260428.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"Article III, Section 2 of the Company’s By-Laws was amended to decrease the number of directors to thirteen, effective April 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/51143/000005114326000043/0000051143-26-000043-index.htm"}},{"accession":"0001692063-26-000022","ticker":"SNDR","company_name":"Schneider National, Inc.","filed_at":"2026-05-01T23:59:59+00:00","headline":"Shareholders approve 19.9M share increase in Omnibus Incentive Plan; bylaw changes adopted","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001692063-26-000022","json":"https://secwatch.observer/filing/0001692063-26-000022.json","markdown":"https://secwatch.observer/filing/0001692063-26-000022.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692063/000169206326000022/0001692063-26-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692063/000169206326000022/sndr-20260430.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"On April 30, 2026, the Board of the Company approved Amended and Restated Bylaws of the Company to provide that the lead independent director (if any) may call special meetings of the Board and will act as chair of meetings of the Company’s stockholders and of the Board in the absence, inability, or refusal to act of the Chair of the Board. In addition, in the event of a vacancy in the office of Chair because of death, resignation, removal, disqualification, or otherwise in which the Board does not appoint a successor Chair, the lead independent director (if a lead independent director has been duly elected) or Chief Executive Officer (if no lead independent director has been duly elected) shall be the Chair and assume the duties, responsibilities, and authority of the office of Chair until a successor is appointed by the Board.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1692063/000169206326000022/0001692063-26-000022-index.htm"}},{"accession":"0000037785-26-000087","ticker":"FMC","company_name":"FMC CORP","filed_at":"2026-04-29T23:59:59+00:00","headline":"FMC director Dirk Kempthorne dies; shareholders reject supermajority elimination proposals","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000037785-26-000087","json":"https://secwatch.observer/filing/0000037785-26-000087.json","markdown":"https://secwatch.observer/filing/0000037785-26-000087.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/37785/000003778526000087/0000037785-26-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/37785/000003778526000087/fmc-20260428.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"stockholders approved certain amendments (the “ Charter Amendments ”) to the Company’s Restated Certificate of Incorporation (the “ Certificate of Incorporation ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/37785/000003778526000087/0000037785-26-000087-index.htm"}},{"accession":"0001104659-26-051495","ticker":"IACQ","company_name":"Irenic Acquisition Corp.","filed_at":"2026-04-29T23:59:59+00:00","headline":"Irenic Acquisition Corp. closes $220M IPO; trust funded with $220M for business combination","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-051495","json":"https://secwatch.observer/filing/0001104659-26-051495.json","markdown":"https://secwatch.observer/filing/0001104659-26-051495.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2122505/000110465926051495/0001104659-26-051495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2122505/000110465926051495/tm269391d12_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"On April 27, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2122505/000110465926051495/0001104659-26-051495-index.htm"}},{"accession":"0001213900-26-049354","ticker":"CXII","company_name":"Churchill Capital Corp XII","filed_at":"2026-04-29T23:59:59+00:00","headline":"Churchill Capital Corp XII closes upsized $414M SPAC IPO; units trade on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-049354","json":"https://secwatch.observer/filing/0001213900-26-049354.json","markdown":"https://secwatch.observer/filing/0001213900-26-049354.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2114227/000121390026049354/0001213900-26-049354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2114227/000121390026049354/ea0288158-8k_churchill12.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm","comparable_excerpt":"On April 27, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 27, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2114227/000121390026049354/0001213900-26-049354-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}